Aline Réal

Dr. Aline Réal

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2024 in Antibodies
Verified
Journal Article
Open access
PDF file
MMMarta Freitas Monteiro
Marta Freitas Monteiro
MPMaria Papaserafeim
Maria Papaserafeim
MAMatteo Andreani
Matteo Andreani
ARAline Réal
Aline Réal
AKAthanasios Kouklas
Athanasios Kouklas
GYGisella L. Puga Yung
Gisella L. Puga Yung
Natural killer (NK) cells play an important role in the surveillance of viral infections and cancer. NK cell antibody-dependent cellular cytotoxicity (ADCC) and direct cytotoxicity are mediated by the recognition of antibody-coated target cells through the Fc gamma receptor IIIA (FcγRIIIa/CD16) and by ligands of activating/inhibitory NK receptors, respectively. Allelic variants of the FCGR3A gene include the high-affinity single-nucleotide polymorphism (SNP) rs396991 (V176F), which is associated with the efficacy of monoclonal antibody (mAb) therapies, and the SNP rs10127939 (L66H/R). The contribution of FCGR3A SNPs to NK cell effector functions remains controversial; therefore, we generated a panel of eight NK-92 cell lines expressing specific combinations of these SNPs and tested their cytotoxicities. NK-92 cells were stably transfected with plasmids containing different combinations of FCGR3A SNPs. Messenger RNA and FcγRIIIa/CD16 cell surface expressions were detected using new generation sequencing (NGS) and flow cytometry, respectively. All FcγRIIIa/CD16-transfected NK-92 cell lines exhibited robust ADCC against three different target cell lines with minor differences. In addition, enhanced direct NK cytotoxicity against K562 target cells was observed, suggesting a mechanistic role of FcγRIIIa/CD16 in direct NK cytotoxicity. In conclusion, we generated eight FcγRIIIa/CD16-transfected NK-92 cell lines carrying different combinations of two of the most studied FCGR3A SNPs, representing the major genotypes described in the European population. The functional characterization of these cell lines revealed differences in ADCC and direct NK cytotoxicity that may have implications for the design of adoptive cancer immunotherapies using NK cells and tumor antigen-directed mAbs.

3 July 2020 in Journal of Leukocyte Biology
Verified
Journal Article
Closed access
PDF file
MMMarta Freitas Monteiro
Marta Freitas Monteiro
MPMaria Papaserafeim
Maria Papaserafeim
ARAline Réal
Aline Réal
GYGisella L. Puga Yung
Gisella L. Puga Yung
JSJörg D Seebach
Jörg D Seebach

4 May 2026 in medRxiv
Verified
Preprint
Open access
PDF file
JHJack Humphrey
Jack Humphrey
AOAli Oku
Ali Oku
MBMarta Byrska-Bishop
Marta Byrska-Bishop
ABAnna O. Basile
Anna O. Basile
UEUday S. Evani
Uday S. Evani
HPHemali Phatnani
Hemali Phatnani
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease with substantial genetic and clinical heterogeneity that impedes therapeutic development. Large-scale multi-tissue genomic resources have transformed the study of neuropsychiatric and neurodegenerative diseases, but no equivalent resource exists for ALS. Here we present the full NYGC ALS Consortium dataset, combining whole-genome sequencing from 4,746 donors and bulk RNA-seq from 2,574 samples across 8 brain and spinal cord regions from 695 donors across the ALS disease spectrum. Our catalogue of small variants, structural variants, and short tandem repeats identified likely pathogenic mutations in 15.6% of ALS cases. Gene expression and mRNA splicing analysis across 5 major tissues reveals shared and region-specific features, highlighting microglial and T-cell dysregulation in the spinal cord. Mapping the genetic regulation of expression and splicing across tissues identified associations with 6 ALS risk loci, whereas allele-specific rare variant analysis detected expression effects for C9orf72 and OPTN . All data are immediately publicly available.

26 September 2025 in medRxiv
Verified
Preprint
Open access
PDF file
ARAline Réal
Aline Réal
KBKailash Bp
Kailash Bp
WDWinston H. Dredge
Winston H. Dredge
BMBenjamin Z. Muller
Benjamin Z. Muller
BJBeomjin Jang
Beomjin Jang
DKDavid A. Knowles
David A. Knowles
Alternative splicing shapes isoform diversity and gene dosage but how genetic variation impacts splicing in brain disease is still not fully characterized. We assembled BigBrain, a multi-ancestry resource of 10,725 bulk RNA-seq profiles with matched genotypes from 4,656 individuals across 43 tissue-cohort pairs, and mapped 68,358 cis -sQTLs affecting 10,966 genes using mixed-model meta-analysis. Using SuSiE, we finemapped over half of these sQTLs into 95% credible sets, frequently to a single variant near splice sites. We further annotated variants predicted to alter dosage through frameshifts or nonsense-mediated decay or disrupt protein domains. Colocalization with seven neurodegenerative and psychiatric GWAS highlighted 97 loci where alternative splicing appears to mediate genetic risk. Among sQTL-eQTL pairs with colocalization probability ≥ 0.8 (posterior probability of a shared causal variant), half shared credible-set variants, showing that splicing can complement or act independently of expression. Mechanistic examples include CAMLG (Parkinson’s), ZDHHC2 (Schizophrenia), and CLU (Alzheimer’s).

3 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
WDWinston H. Dredge
Winston H. Dredge
BKBp Kailash
Bp Kailash
ARAline Réal
Aline Réal
BMBenjamin Z. Muller
Benjamin Z. Muller
BJBeomjin Jang
Beomjin Jang
TRTowfique Raj
Towfique Raj
Adenosine-to-inosine (A-to-I) RNA editing is among the most abundant post-transcriptional modifications, whose role in homeostasis and disease of the central nervous system (CNS) has been extensively reported. Regulation of A-to-I editing by cis -acting genetic variants (edQTLs) is understudied, especially in the brain. As a part of the BigBrain Project (n=4,471 individuals), which represents a >10-fold increase in sample size from previous edQTL studies, we harmonized A-to-I sites across datasets to perform a meta-analysis that identified 38,731 edQTLs in 3,554 genes. Integrating other QTL summary statistics from BigBrain, we show edQTLs in 3’ untranslated regions (3’UTR) are more likely to share a genetic effect with gene expression or splicing. Using colocalization analysis, we identify 24 GWAS loci for neurological disorders explained by edQTLs alone, or in concert with other molecular QTLs. This study represents a valuable resource to the field of RNA editing and neurogenetics.